Becton, Dickinson and Company BDX
NYSE · United States · Health Technology
$179.00-2.97 (-1.63%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Zacks cited Becton Dickinson’s growth initiatives and cost savings, while warning that reimbursement uncertainty and competition remain challenges.
RMD has trailed healthcare stocks over 12 months, but improving earnings, cash flow and buybacks complicate the bearish case.